RSBT-001

N/A

Report date: 2023/09/26 16:27:02
NME

Base Information

Drug NameRSBT-001
Drug Alias Namesemi-synthetic, cannabidiolic acid (CBDa) complexRSBT-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMarshall UniversitySynthonics IncRS Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynthonics IncRS Biotherapeutics IncMarshall University
Inactive CompaniesN/A
Active IndicationsPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A